Detalhe da pesquisa
1.
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.
Int J Cancer
; 147(2): 413-422, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31714586
2.
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 122(7): 1119, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31949268
3.
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
Breast Cancer Res Treat
; 181(2): 347-359, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32274665
4.
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial.
Lancet Oncol
; 20(4): 570-580, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30880072
5.
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Br J Cancer
; 120(10): 959-967, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30967649
6.
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 19(1): 127-138, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158011
7.
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
N Engl J Med
; 371(2): 107-18, 2014 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24881463
8.
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
Lancet Oncol
; 16(7): 848-58, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26092816
9.
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.
Lancet Oncol
; 15(11): 1207-14, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25218906
10.
Emerging Adult and Caregiver Psychosocial Experiences with Severe Hypoglycemic Events and the Perceived Impact of Nasal Glucagon: A Cross-Sectional Study.
Diabetes Ther
; 14(8): 1285-1298, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268778
11.
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial.
JAMA Oncol
; 5(12): 1731-1738, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31600397
12.
Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer.
J Clin Oncol
; 37(30): 2786-2794, 2019 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31461377
13.
Adherence to guidelines for use of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia: results of a retrospective study of an electronic medical-records database in the United States, 2002-2006.
Clin Ther
; 30(12): 2423-35, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19167601
14.
Use of erythropoiesis-stimulating agents among chemotherapy patients with hemoglobin exceeding 12 grams per deciliter.
J Manag Care Pharm
; 14(9): 858-69, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19006442
15.
Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity.
Int J Radiat Oncol Biol Phys
; 67(5): 1299-308, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17275202
16.
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.
J Clin Oncol
; 35(27): 3113-3122, 2017 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28654365
17.
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.
J Clin Oncol
; 34(14): 1601-10, 2016 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27022111
18.
Incidence of new-onset hypertension in cancer patients: a retrospective cohort study.
Int J Hypertens
; 2013: 379252, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24455206
19.
Reply to F. Tomao et al.
J Clin Oncol
; 34(34): 4189-4190, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27621403
20.
Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials.
Am J Clin Pathol
; 133(4): 646-53, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20231618